Evaxion A (EVAX) Cash & Equivalents (2019 - 2026)

Evaxion A (EVAX) has 8 years of Cash & Equivalents data on file, last reported at $18.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 3.35% year-over-year to $18.4 million; the trailing twelve-month figure through Mar 2026 stood at $18.4 million (up 3.35% YoY), and the FY2025 full-year result was $23.2 million, up 290.36% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $18.4 million, down from $23.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $31.4 million in Q1 2022 and bottomed at $11731.0 in Q1 2024.
• The 5-year median for Cash & Equivalents is $11.9 million (2022), against an average of $13.3 million.
• The widest annual swing landed in 2024, when Cash & Equivalents plunged 99.89%; it then soared 152001.27% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $13.2 million in 2022, then plunged by 57.65% to $5.6 million in 2023, then rose by 6.61% to $6.0 million in 2024, then surged by 290.36% to $23.2 million in 2025, then decreased by 20.63% to $18.4 million in 2026.
• The last three Cash & Equivalents figures came in at $18.4 million (Q1 2026), $23.2 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.

Peer Comparison